Clinical trial
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved…
NCT00094302 · Carelon Research, Other · Completed
Key facts
| NCT number | NCT00094302 |
|---|---|
| Title | Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function |
| Official title | Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) |
| Acronym | TOPCAT |
| Lead sponsor | Carelon Research, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases, Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Spironolactone, Placebo |
| Enrollment | 3,445 |
| Start date | Aug 1, 2006 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Oct 15, 2004 |
| Last update posted | Mar 2, 2015 |
| Countries | Argentina, Brazil, Canada, Georgia, Russia, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: